CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent 5-Year Outcomes of the Randomized BIOFLOW-II Trial Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up

Original Research2016 Jul 19;68(3):313-321.

JOURNAL:J Am Coll Cardiol. Article Link

Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines

Rodriguez F, Mahaffey KW. Keywords: acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment

FULL TEXT PDF